Iota Pharmaceuticals Limited
06279987
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
30/06/2024
total exemption full
Next accounts due
29/03/2026
Confirmation statement
Last: 14/06/2025
Due 28/06/2026
Industry
Officers
director · Since 20/09/2007
SCIENTIST
BRITISH · ENGLAND · Age 58
Also on 1 other board
director · Since 20/09/2007
BIOTECHNOLOGY CONSULTANT
BRITISH · ENGLAND · Age 82
Also on 3 other boards
secretary · Since 26/06/2014
Persons with Significant Control
Vu Holding B.V.
1081a, De Boelelaan 1081a, Amsterdam
Reg: 34281690 · Dutch Chamber Of Commerce · Limited Company
Notified 06/04/2016
CompanyRankvs 1634+ SIC 72110 peers52
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2024
Net Worth
-£15k
Balance sheet strength
Cash
£15k
Cash in the bank
Profit Before Tax
-£913
Bottom line earnings
Net Current Assets
-£15k
Working capital
Current Assets
£17k
Current Liabilities
£32k
Debtors
£2k
Admin Expenses
£12k
Operating Profit
-£913
Profit After Tax
-£913
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.54 | -£913 |
| 2023 | 0.89 | — |
| 2020 | 3.55 | — |
| 2019 | 1.23 | — |
| 2018 | 1.20 | — |
Derived from filed accounts. Not audited figures.